Follow
Barca Martín, Alejandro
Barca Martín, Alejandro
Verified email at estudiante.uam.es
Title
Cited by
Cited by
Year
Long term follow-up of the PRIMA study: half of patients receiving rituximab maintenance remain progression free at 10 years
GA Salles, JF Seymour, P Feugier, F Offner, A Lopez-Guillermo, D Belada, ...
Blood 130, 486, 2017
652017
Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma
TH Chen‐Liang, T Martín‐Santos, A Jerez, G Rodríguez‐García, L Senent, ...
Cancer medicine 6 (11), 2507-2514, 2017
182017
Cuidados en los últimos días de vida en los pacientes hospitalizados en medicina interna
J Díez-Manglano, SI de Isasmendi Pérez, MR Gómez, F Formiga, ...
Revista Clínica Española 219 (3), 107-115, 2019
152019
Phase II study of yttrium-90-ibritumomab tiuxetan as part of reduced-intensity conditioning (with melphalan, fludarabine±thiotepa) for allogeneic transplantation in relapsed or …
M Cabrero, A Martin, J Briones, J Gayoso, I Jarque, J López, C Grande, ...
Biology of Blood and Marrow Transplantation 23 (1), 53-59, 2017
152017
Las cuestiones ético-jurídicas más relevantes en relación con los biobancos
A Martín, MC Martín-Arribas, JH di Donato, M Posada
Instituto de Salud Carlos III. Madrid, 2005
142005
Palliative sedation in patients hospitalized in internal medicine departments
J Díez-Manglano, SI de Isasmendi Pérez, RG Fenoll, LÁ Sánchez, ...
Journal of Pain and Symptom Management 59 (2), 302-309, 2020
122020
Una experiencia dentro de la conceptualización personalizada en el aula de infantil: las matemáticas y el cuerpo humano
A Mateos Martín, J Macías Sánchez, B Arteaga Martínez
112016
Safety and preliminary antitumor activity of the anti-PD-1 monoclonal antibody REGN2810 alone or in combination with REGN1979, an anti-CD20 x anti-CD3 bispecific antibody, in …
MS Topp, P Borchmann, ND Wagner-Johnston, M Provencio, R Cordoba, ...
Blood 130, 1495, 2017
102017
Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma
A Jiménez‐Ubieto, C Grande, D Caballero, L Yáñez, S Novelli, ...
Cancer Medicine 6 (12), 2766-2774, 2017
102017
Post relapse survival rates in diffuse large B-cell lymphoma
A McMillan, A Martín, C Haioun, A Chiappella, A Di Rocco, A Rueda, ...
Blood 128 (22), 4204, 2016
102016
A new graphic cryptosystem based on one-dimensional memory cellular automata
G Alvarez, A Hernandez, L Hernandez, A Martin, G Rodriguez
Proceedings 39th annual 2005 international carnahan conference on security …, 2005
82005
DíAz, y
A MArTin
MiloslAviCh, P., es-CoBAr-Briones, e., guerrA-gArCíA, JM, orTiz, M …, 2013
62013
Prognostic significance of unplanned start of dialysis. A Spanish multicentrical study
JL Górriz, A Sancho, LM Pallardó, ML Amoedo, A Martin, P Sanz, G Barril, ...
Nefrología 22 (1), 49-59, 2002
42002
Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-cell lymphoma: Final results of the R2-GDP-GOTEL trial.
L de la Cruz Merino, A Martin, E Nogales Fernandez, ...
Journal of Clinical Oncology 38 (15_suppl), 8019-8019, 2020
3*2020
Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León
JA Rodríguez-García, L Vázquez, F Ramos, B Cuevas, A Martín, ...
Medicina Clínica 144 (11), 491-500, 2015
32015
The Presence of Residual Normal Plasma Cells by Multiparameter Flow Cytometry in the Bone Marrow of Symptomatic Multiple Myeloma Patients at Diagnosis Identifies A Good …
B Paiva, M Vidriales, J Cervero, G Mateo, J Perez, MA Montalban, ...
Haematologica-the Hematology Journal, 2012
32012
Development of a global-through-urban scale nested air quality forecast model (RSM-ANA): Application over the Madrid domain
RS JosÉ, I Salas, A MartÍn, JL Pérez, AB Carpintero, MC Ramos, JI Pena, ...
Systems Analysis Modelling Simulation 42 (11), 1551-1560, 2002
32002
Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients …
E González-Barca, E Carrillo-Cruz, C Grande, A Martín, M Coronado, ...
Blood 128 (22), 4201, 2016
22016
Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group
M Coronado, E Pardal, R Couto, F de la Cruz, C Panizo, C Grande, ...
Blood, The Journal of the American Society of Hematology 120 (21), 5076-5076, 2012
22012
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome
A Martín, MD Caballero
Haematologica 94 (5), 744-744, 2009
22009
The system can't perform the operation now. Try again later.
Articles 1–20